rs1064448

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001114.5(ADCY7):​c.*1467T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 152,646 control chromosomes in the GnomAD database, including 12,720 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 12656 hom., cov: 32)
Exomes 𝑓: 0.46 ( 64 hom. )

Consequence

ADCY7
NM_001114.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.259

Publications

20 publications found
Variant links:
Genes affected
ADCY7 (HGNC:238): (adenylate cyclase 7) This gene encodes a membrane-bound adenylate cyclase that catalyses the formation of cyclic AMP from ATP and is inhibitable by calcium. The product of this gene is a member of the adenylyl cyclase class-4/guanylyl cyclase enzyme family that is characterized by the presence of twelve membrane-spanning domains in its sequences. Several transcript variants have been observed for this gene, but the full-length natures of only two have been determined so far. [provided by RefSeq, Oct 2013]
BRD7 (HGNC:14310): (bromodomain containing 7) This gene encodes a protein which is a member of the bromodomain-containing protein family. The product of this gene has been identified as a component of one form of the SWI/SNF chromatin remodeling complex, and as a protein which interacts with p53 and is required for p53-dependent oncogene-induced senescence which prevents tumor growth. Pseudogenes have been described on chromosomes 2, 3, 6, 13 and 14. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.495 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADCY7NM_001114.5 linkc.*1467T>G 3_prime_UTR_variant Exon 26 of 26 ENST00000673801.1 NP_001105.1 P51828Q86YI0
BRD7NM_013263.5 linkc.*2239A>C 3_prime_UTR_variant Exon 17 of 17 ENST00000394688.8 NP_037395.2 Q9NPI1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADCY7ENST00000673801.1 linkc.*1467T>G 3_prime_UTR_variant Exon 26 of 26 NM_001114.5 ENSP00000501053.1 P51828
BRD7ENST00000394688.8 linkc.*2239A>C 3_prime_UTR_variant Exon 17 of 17 1 NM_013263.5 ENSP00000378180.3 Q9NPI1-1

Frequencies

GnomAD3 genomes
AF:
0.379
AC:
57543
AN:
151954
Hom.:
12657
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.146
Gnomad AMI
AF:
0.548
Gnomad AMR
AF:
0.418
Gnomad ASJ
AF:
0.499
Gnomad EAS
AF:
0.209
Gnomad SAS
AF:
0.428
Gnomad FIN
AF:
0.447
Gnomad MID
AF:
0.532
Gnomad NFE
AF:
0.500
Gnomad OTH
AF:
0.419
GnomAD4 exome
AF:
0.458
AC:
263
AN:
574
Hom.:
64
Cov.:
0
AF XY:
0.455
AC XY:
153
AN XY:
336
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.493
AC:
68
AN:
138
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.446
AC:
183
AN:
410
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
11
AN:
22
Other (OTH)
AF:
0.250
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.379
AC:
57570
AN:
152072
Hom.:
12656
Cov.:
32
AF XY:
0.376
AC XY:
27915
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.146
AC:
6070
AN:
41518
American (AMR)
AF:
0.418
AC:
6389
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.499
AC:
1731
AN:
3472
East Asian (EAS)
AF:
0.210
AC:
1082
AN:
5164
South Asian (SAS)
AF:
0.430
AC:
2072
AN:
4818
European-Finnish (FIN)
AF:
0.447
AC:
4715
AN:
10556
Middle Eastern (MID)
AF:
0.541
AC:
159
AN:
294
European-Non Finnish (NFE)
AF:
0.500
AC:
33969
AN:
67954
Other (OTH)
AF:
0.419
AC:
884
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1684
3368
5052
6736
8420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.459
Hom.:
19805
Bravo
AF:
0.368
Asia WGS
AF:
0.324
AC:
1128
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.5
DANN
Benign
0.59
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1064448; hg19: chr16-50350883; API